Docetaxel Injection is a microtubule inhibitor indicated for:
• Breast Cancer (BC): single agent for locally advanced
or metastatic BC after chemotherapy failure; and with
doxorubicin and cyclophosphamide as adjuvant
treatment of operable node-positive BC
• Non-small Cell Lung Cancer (NSCLC): single agent for
locally advanced or metastatic NSCLC after platinum
therapy failure; and with cisplatin for unresectable, locally
advanced or metastatic untreated NSCLC
• Castration-Resistant Prostate Cancer (CRPC): with
prednisone in metastatic castration-resistant prostate
cancer
• Gastric Adenocarcinoma (GC): with cisplatin and
fluorouracil for untreated, advanced GC, including
the gastroesophageal junction
• Squamous Cell Carcinoma of the Head and Neck
(SCCHN): with cisplatin and fluorouracil for induction treatment of locally advanced SCCHN.
